Alpha arbutin is a form of arbutin, a molecule made of hydroquinone bound to a sugar (glucose) and used in products aimed at dark spots [1, 2]. In the lab it blocks tyrosinase, the enzyme that starts melanin production [3]. Human studies, though, are small, short and mostly test multi-ingredient formulas. For melasma or any spot you can’t explain, see a dermatologist.
In this article
What is alpha arbutin?
Alpha arbutin is one of two forms of arbutin, a compound of hydroquinone and D-glucose whose skin-lightening action has been studied for more than 30 years [1]. That tie to hydroquinone explains both why arbutin can reduce pigment and why its safety keeps being discussed.
On labels, “arbutin” alone usually means beta arbutin; “alpha-arbutin” is the other form. Both are built from the same two pieces and differ in how the sugar is attached [2]. The type of spot changes what any product can do, so read our dark spots guide before you pick one.
Beta arbutin vs alpha arbutin: what’s the difference?
In an enzyme experiment using tyrosinase from human melanoma cells, alpha arbutin inhibited the enzyme more strongly than arbutin; its binding constant (Ki value) was 1/20 of arbutin’s [2]. That is a test-tube result. It does not mean alpha arbutin works twenty times better on your face.
| Alpha arbutin | Arbutin (beta arbutin) | |
|---|---|---|
| On the label | alpha-arbutin | arbutin |
| Human tyrosinase (enzyme test) | Stronger inhibition | Weaker inhibition |
| Upper limit the SCCS judged safe | Face cream 2%, body lotion 0.5% | Face cream 7%, hydroquinone below 1 ppm |
| Stability in formulas | Depends on formula type and pH | Similar profile |
The limits come from the EU Scientific Committee on Consumer Safety (SCCS) [8, 9]; the stability row from cosmetic products analyzed when opened and after 16 months, where both forms behaved alike [10]. No human study we found compares the two forms on skin.
What does arbutin do for skin?
Arbutin is meant to lower melanin production so that dark spots look lighter. That effect is clear in cell experiments. Human trials are small, often uncontrolled, and many mix arbutin with other actives, so the evidence for dark spots is limited.
How does it act on tyrosinase?
Tyrosinase starts the production of melanin, the pigment that colors skin. In cultured human melanocytes (pigment cells), arbutin suppressed tyrosinase activity and melanin production at concentrations that did not harm the cells. It blocked how the enzyme works, not how much of it was made, and the effect was reversible [3].
The human enzyme tells a less tidy story. In a large screen using recombinant human tyrosinase, arbutin inhibited it only weakly, in the millimolar range [11]. The authors note that many ingredients fail in the clinic because they were found using mushroom tyrosinase. The molecule the study promoted came from a cosmetics company, a conflict of interest to keep in mind.
What did dark spot and melasma trials find?
The largest controlled trial enrolled 102 women with melasma or sun spots (solar lentigines). They applied either a cream with a plant extract carrying 2.51% arbutin or a control cream, twice daily for 8 weeks. The extract cream lowered melanin in the spots, and lightening was seen in 75.86% of the women with melasma and 56.00% of those with sun spots [6]. But the abstract reports neither the control group’s results nor a comparison between groups, so we can’t say how much of the change belongs to the cream.
In a small open-label study from Turkey, 30 people with melasma were split across three gels; all 10 in the arbutin group had a significant drop in melanin [12]. There was no placebo group, and the abstract gives no concentration or duration.
In a split-face pilot trial, 30 people with melasma applied a cream with 5% alpha arbutin and 2% kojic acid to one half of the face and a prescription triple combination cream to the other for 12 weeks. Changes in melanin index and melasma severity score did not differ between sides, while the physician’s global rating improved only on the prescription side [5]. Note that 5% alpha arbutin is above the 2% the SCCS judged safe for face creams [8].
A systematic review of 35 randomized melasma trials gave strong recommendations only to cysteamine, triple combination therapy and tranexamic acid, and called for more research on natural compounds [13]. Melasma is a medical condition for a dermatologist to diagnose and treat.
Who gets the credit in multi-ingredient formulas?
Arbutin has been tested clinically on its own and alongside other actives [1]. In a single-arm study of 124 women in India, a formula with 2% alpha arbutin and 10% trihydroxybenzoic acid glucoside was used for 90 days together with daily sunscreen. Among the 120 people analyzed, spot melanin fell by 16.3% and melasma score by 18.4% [4]. With no control group and sunscreen built into the regimen, nobody can tell how much of that came from alpha arbutin. The review also notes that arbutin combined with laser may enhance depigmentation [1], but that concerns a clinical procedure, not a home routine.
How do you use alpha arbutin?
Alpha arbutin serums usually go on clean skin before moisturizer. That order is practical advice; our sources contain no layering study specific to arbutin. In the clinical studies, arbutin products were applied twice daily [6, 4]. Whatever else you do, finish every morning routine with sunscreen.
- Wash with a gentle cleanser and pat dry.
- Apply a thin layer of the alpha arbutin serum or cream.
- Follow with moisturizer.
- Finish mornings with sunscreen.
In practice, patch test a new product on a small area for a few days and add it on its own, so you know what caused any reaction.
What percentage of alpha arbutin should you use?
For a face product listing alpha arbutin, the upper limit the SCCS judged safe is 2%; for body lotion it is 0.5% [8]. For beta arbutin in face creams, the limit is 7%, on the condition that hydroquinone in the formula stays below 1 ppm [9]. These are safety ceilings, not efficacy targets; no comparative study we found shows a higher percentage works better. The opinions date from 2015 and 2016, and current rules where you live may differ.
When is the best time to use alpha arbutin?
No study in our sources compares morning with evening use. In the controlled plant extract trial the cream was applied twice daily [6]; in the 90-day study the formula was used twice daily and sunscreen once daily [4]. A simple start is to use it at night and keep mornings for sunscreen, unless your product’s directions say otherwise.
Why sunscreen still matters
Sunscreen was part of the regimen in some dark spot studies [4], so don’t assume the same result on unprotected skin. In practice, make a broad-spectrum sunscreen the last step of every morning; our sunscreen guide covers how much to apply and when to reapply.
What happens when you use alpha arbutin?
Don’t expect visible change in the first few weeks. Studies measured results at 8 to 12 weeks, usually as a drop in melanin on a measuring device rather than a vanished spot [6, 5]. Irritation was rare, but watch your skin as with any new product.
| Time point | What the study measured | Source |
|---|---|---|
| Week 8 | Lower melanin in spots with the plant extract cream | [6] |
| Week 12 | Alpha arbutin plus kojic acid: melanin and severity score no different from prescription cream | [5] |
| Day 90 | Multi-ingredient formula plus sunscreen: 16.3% lower spot melanin | [4] |
| 4 weeks after stopping | Relapse more severe on the prescription side | [5] |
These are the studies’ measurement points, not a promise of the same result on your skin.
Arbutin rarely causes dermatitis (an inflamed rash) [1]. The 90-day study reported no itching, burning or irritation [4]; in the split-face trial, redness and stinging were more common on the prescription side [5]. If redness, itching or swelling appears, stop; if it persists, see a dermatologist.
What can you use alpha arbutin with?
You can use alpha arbutin in the same routine as niacinamide (a form of vitamin B3), sunscreen and moisturizer; studies often tested arbutin alongside other ingredients [1]. The real caution: the safety opinions did not assess combined use with other substances that release hydroquinone [8, 9].
| Ingredient | Together? | Note |
|---|---|---|
| Niacinamide | Yes | Tested in one combined cream, see below |
| Vitamin C | No harm shown | Not tested directly, see below |
| Sunscreen | Every morning | Part of a study regimen [4] |
| Retinol or AHA/BHA | On separate nights if irritated | Practical advice |
| Products containing or releasing hydroquinone | Not without asking your doctor | Combined use not assessed |
Niacinamide: in a single-arm study in epidermal melasma, a cream with 4% niacinamide, 3% arbutin and two other actives reduced melasma scores and was well tolerated [7]; without a control group, the pair’s own effect is unknown. See the niacinamide guide.
Vitamin C: no study we found tests this pair, and no data suggest a problem. Vitamin C (L-ascorbic acid) in the morning and alpha arbutin at night makes irritation easier to trace. See the vitamin C guide, and the niacinamide and vitamin C guide if you use all three.
You don’t need several brightening actives at once; azelaic acid has its own evidence base, and adding one product at a time keeps reactions traceable.
Who should be careful with alpha arbutin?
Dermatitis from arbutin is rare. The real debate is that hydroquinone may form while the product is in use, which is why the review advises caution with arbutin products [1]. Hydroquinone is a stronger lightener than arbutin, but it shows toxicity to cells, kidneys and genetic material [14].
In a lab experiment, every strain tested of two common skin bacteria broke arbutin down into hydroquinone; how much forms on real skin was not measured [14]. In the 16-month product analysis, arbutin’s stability depended on formula type and pH (acidity). Under strong hydrolytic conditions (breakdown by water), both alpha and beta arbutin released hydroquinone [10]. The SCCS opinion on beta arbutin is likewise conditional on hydroquinone in the formula staying below 1 ppm [9].
- Pregnancy and breastfeeding: no arbutin-specific study in our sources; see the FAQ below and ask your doctor.
- Melasma: this is a medical condition, and arbutin is not among the agents with a strong recommendation in the melasma review [13]. See a dermatologist for diagnosis and treatment.
- Sensitive skin: patch test first. If you use a prescription treatment for pigment, ask your doctor before adding arbutin.
Choosing and storing alpha arbutin products
Start with the label: does it say “alpha-arbutin” or just “arbutin”? The limits judged safe differ between the two [8, 9], so compare any listed percentage with them. Because stability depends on formula type and pH, don’t mix the product with others yourself [10]. For storage and the period after opening, follow the label (practical advice).
Frequently asked questions
Is alpha arbutin safe for pregnancy?
Our sources cannot confirm that it is. No study we found tested arbutin in pregnancy, and hydroquinone, to which arbutin is chemically tied, is a noted exception among skincare ingredients because of its relatively high absorption [15]. Talk to your doctor or midwife before using it while pregnant or breastfeeding.
Can you make alpha arbutin serum at home?
We don’t recommend it. Arbutin’s stability in cosmetic formulas depended on formula type and pH, and under strong hydrolytic conditions it released hydroquinone [10]. A homemade serum from powder leaves both the percentage and the pH uncertain, so you can’t check it against the 2% face limit [8].
Is alpha arbutin good for sensitive skin?
It may be tolerable, but sensitive skin has not been studied specifically. Dermatitis is described as rare [1] and the 90-day study reported no irritation [4]. Patch test first and introduce it on its own.
Does alpha arbutin lighten your overall skin tone?
That is not what the studies measured. They looked at melanin in dark spots and at melasma scores, not at lightening healthy skin [6, 4]. A natural skin tone is not something that needs correcting.
References
- Boo YC. Arbutin as a Skin Depigmenting Agent with Antimelanogenic and Antioxidant Properties. Antioxidants (Basel). 2021;10(7). PubMed · DOI
- Sugimoto K, Nishimura T, Nomura K, Sugimoto K, Kuriki T. Syntheses of arbutin-alpha-glycosides and a comparison of their inhibitory effects with those of alpha-arbutin and arbutin on human tyrosinase. Chem Pharm Bull (Tokyo). 2003;51(7):798-801. PubMed · DOI
- Maeda K, Fukuda M. Arbutin: mechanism of its depigmenting action in human melanocyte culture. J Pharmacol Exp Ther. 1996;276(2):765-769. PubMed
- Gabhane M, Patil R, Dharmadhikari S, Shah P, Khandhedia C, Mehta S. Efficacy and Safety of a Topical Formulation Containing Trihydroxybenzoic Acid Glucoside and α-Arbutin, Applied Along With a Sunscreen: A Noncomparative, Prospective, Interventional Study in Indian Females With Facial Melasma or Dark Spots. J Cosmet Dermatol. 2025;24(2):e70017. PubMed · DOI
- Tantanasrigul P, Sripha A, Chongmelaxme B. The Efficacy of Topical Cosmetic Containing Alpha-Arbutin 5% and Kojic Acid 2% Compared With Triple Combination Cream for the Treatment of Melasma: A Split-Face, Evaluator-Blinded Randomized Pilot Study. J Cosmet Dermatol. 2025;24(1):e16562. PubMed · DOI
- Morag M, Nawrot J, Siatkowski I, et al. A double-blind, placebo-controlled randomized trial of Serratulae quinquefoliae folium, a new source of β-arbutin, in selected skin hyperpigmentations. J Cosmet Dermatol. 2015;14(3):185-190. PubMed · DOI
- Crocco EI, Veasey JV, Boin MF, Lellis RF, Alves RO. A novel cream formulation containing nicotinamide 4%, arbutin 3%, bisabolol 1%, and retinaldehyde 0.05% for treatment of epidermal melasma. Cutis. 2015;96(5):337-342. PubMed
- Sccs, Degen GH. Opinion of the Scientific Committee on Consumer safety (SCCS)—Opinion on the safety of the use of α-arbutin in cosmetic products. Regul Toxicol Pharmacol. 2016;74:75-76. PubMed · DOI
- SCCS, Degen GH. Opinion of the Scientific Committee on Consumer Safety (SCCS)—Opinion on the safety of the use of β-arbutin in cosmetic products. Regul Toxicol Pharmacol. 2015;73(3):866-867. PubMed · DOI
- Avonto C, Wang YH, Avula B, Wang M, Rua D, Khan IA. Comparative studies on the chemical and enzymatic stability of alpha- and beta-arbutin. Int J Cosmet Sci. 2016;38(2):187-193. PubMed · DOI
- Mann T, Gerwat W, Batzer J, et al. Inhibition of Human Tyrosinase Requires Molecular Motifs Distinctively Different from Mushroom Tyrosinase. J Invest Dermatol. 2018;138(7):1601-1608. PubMed · DOI
- Ertam I, Mutlu B, Unal I, Alper S, Kivçak B, Ozer O. Efficiency of ellagic acid and arbutin in melasma: a randomized, prospective, open-label study. J Dermatol. 2008;35(9):570-574. PubMed · DOI
- Austin E, Nguyen JK, Jagdeo J. Topical Treatments for Melasma: A Systematic Review of Randomized Controlled Trials. J Drugs Dermatol. 2019;18(11):1156-1171. PubMed
- Bang SH, Han SJ, Kim DH. Hydrolysis of arbutin to hydroquinone by human skin bacteria and its effect on antioxidant activity. J Cosmet Dermatol. 2008;7(3):189-193. PubMed · DOI
- Bozzo P, Chua-Gocheco A, Einarson A. Safety of skin care products during pregnancy. Can Fam Physician. 2011;57(6):665-667. PubMed
